Kite Pharma to Participate in Upcoming Investor Conferences in September 2015

SANTA MONICA, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq: KITE) today announced that the management team will participate in two upcoming investor conferences this month:

• 10th Annual Citi Biotech Conference

Date: Thursday, September 10, 2015 Time: 11:00am Eastern Time Location: New York, NY

• Morgan Stanley Global Healthcare Conference

Date: Thursday, September 17, 2015 Time: 1:30pm Eastern Time Location: New York, NY

The Company's corporate overview to be presented at the Morgan Stanley Global Healthcare Conference will be available through the Calendar of Events section of the Company's website at ir.kitepharma.com.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com.

CONTACT: Kite Pharma
         Cynthia M. Butitta
         Chief Financial Officer and Chief Operating Officer
         310-824-9999

         For Media: Justin Jackson
         For Investor Inquiries: Lisa Burns
         Burns McClellan
         212-213-0006
         [email protected]
         [email protected]

You May Also Be Interested In

• TabaPay to Acquire the Assets of Synapse Financial Technologies, Inc.
• Voxtur Engages ICP Securities Inc. for Automated Market Making Services
• Northern Dynasty Makes Annual Filings